Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Pertussis surveillance by small serosurveys of blood donors.

Kennerknecht N, Riffelmann M, Voelker U, Wirsing von König CH.

Epidemiol Infect. 2018 Oct;146(14):1807-1810. doi: 10.1017/S0950268818001851. Epub 2018 Jul 10.

PMID:
29986784
2.

Long-lasting cough in an adult German population: incidence, symptoms, and related pathogens.

Weinberger R, Riffelmann M, Kennerknecht N, Hülße C, Littmann M, O'Brien J, von Kries R, von König CHW.

Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):665-672. doi: 10.1007/s10096-017-3158-6. Epub 2018 Jan 4.

PMID:
29302815
3.

Latent class analysis of diagnostic tests for adenovirus, Bordetella pertussis and influenza virus infections in German adults with longer lasting coughs.

Sobotzki C, Riffelmann M, Kennerknecht N, Hülsse C, Littmann M, White A, Von Kries R, Wirsing VON König CH.

Epidemiol Infect. 2016 Mar;144(4):840-6. doi: 10.1017/S0950268815002149. Epub 2015 Sep 18.

PMID:
26380914
4.

Time since last vaccine dose in PCR-positive and PCR-negative children with suspected pertussis to monitor pertussis vaccine effectiveness.

Riffelmann M, Mohr J, Hellenbrand W, Wirsing von Koenig CH.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):805-8. doi: 10.1007/s10096-013-2016-4. Epub 2013 Dec 1.

PMID:
24292098
5.

The protective role of maternally derived antibodies against Bordetella pertussis in young infants.

Heininger U, Riffelmann M, Bär G, Rudin C, von König CH.

Pediatr Infect Dis J. 2013 Jun;32(6):695-8. doi: 10.1097/INF.0b013e318288b610.

PMID:
23429559
6.

Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Advani A, Hallander HO, Dalby T, Krogfelt KA, Guiso N, Njamkepo E, von Könnig CH, Riffelmann M, Mooi FR, Sandven P, Lutynska A, Fry NK, Mertsola J, He Q.

J Clin Microbiol. 2013 Feb;51(2):422-8. doi: 10.1128/JCM.02036-12. Epub 2012 Nov 21.

7.

External quality assessment of pertussis serology in Germany.

Riffelmann M, Hunfeld KP, Müller I, Xing D, Kennerknecht N, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):421-3. doi: 10.1007/s10096-012-1759-7. Epub 2012 Oct 19.

PMID:
23076769
8.

Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens.

Kennerknecht N, Riffelmann M, Schmetz J, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1531-5. doi: 10.1007/s10096-011-1256-4. Epub 2011 Apr 20.

PMID:
21503838
9.

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group.

Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12. doi: 10.1007/s10096-010-1104-y. Epub 2010 Nov 11. Review.

10.

Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH.

J Clin Microbiol. 2010 Dec;48(12):4459-63. doi: 10.1128/JCM.01371-10. Epub 2010 Oct 13.

11.

Pertussis: not only a disease of childhood.

Riffelmann M, Littmann M, Hülße C, Hellenbrand W, Wirsing von König CH.

Dtsch Arztebl Int. 2008 Sep;105(37):623-8. doi: 10.3238/arztebl.2008.0623. Epub 2008 Sep 12.

12.

[Lifelong protection against pertussis].

Riffelmann M, Wirsing von König CH.

Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S86-9. doi: 10.1055/s-0029-1220216. Epub 2009 Apr 7. German.

PMID:
19353478
13.

Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns.

Heininger U, Riffelmann M, Leineweber B, Wirsing von Koenig CH.

Pediatr Infect Dis J. 2009 May;28(5):443-5. doi: 10.1097/INF.0b013e318193ead7.

PMID:
19319020
14.

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.

Clin Vaccine Immunol. 2009 Mar;16(3):303-11. doi: 10.1128/CVI.00372-08. Epub 2008 Dec 24.

15.

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

Rieber N, Graf A, Belohradsky BH, Hartl D, Urschel S, Riffelmann M, Wirsing von König CH, Liese J.

Vaccine. 2008 Dec 9;26(52):6929-35. doi: 10.1016/j.vaccine.2008.09.064. Epub 2008 Oct 11.

PMID:
18852002
16.

Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine.

Riffelmann M, Littmann M, Hülsse C, von König CH.

Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):275-9. doi: 10.1007/s10096-008-0625-0. Epub 2008 Sep 17.

PMID:
18797942
17.

Cost-effectiveness of adult pertussis vaccination in Germany.

Lee GM, Riffelmann M, Wirsing von Konig CH.

Vaccine. 2008 Jul 4;26(29-30):3673-9. doi: 10.1016/j.vaccine.2008.04.068. Epub 2008 May 19.

PMID:
18538901
18.

Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.

Littmann M, Hülsse C, Riffelmann M, Wirsing von König CH.

Vaccine. 2008 May 2;26(19):2344-9. doi: 10.1016/j.vaccine.2008.02.065. Epub 2008 Mar 19.

PMID:
18396360
19.

Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay.

Reder S, Riffelmann M, Becker C, Wirsing von König CH.

Clin Vaccine Immunol. 2008 May;15(5):744-9. doi: 10.1128/CVI.00225-07. Epub 2008 Mar 5.

20.

Preparation of Bordetella pertussis DNA from respiratory samples for real-time PCR by commercial kits.

Riffelmann M, Schmetz J, Bock S, Wirsing von Koenig CH.

Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):145-8.

PMID:
17965893
21.

Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis.

Hallander H, Advani A, Riffelmann M, von König CH, Caro V, Guiso N, Mooi FR, Gzyl A, Kaltoft MS, Fry NK, Mertsola J, He Q.

J Clin Microbiol. 2007 Oct;45(10):3257-62. Epub 2007 Aug 15.

22.

[Pertussis: incidence, symptoms and costs].

Riffelmann M, Littmann M, Hülsse C, O'Brien J, Wirsing von König CH.

Dtsch Med Wochenschr. 2006 Dec 15;131(50):2829-34. German.

PMID:
17160764
23.

Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer.

Hille S, Rein DT, Riffelmann M, Neumann R, Sartorius J, Pfützner A, Kurbacher CM, Schöndorf T, Breidenbach M.

Anticancer Drugs. 2006 Oct;17(9):1041-4.

PMID:
17001177
24.

Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.

Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, Riffelmann M, Wirsing von König CH.

Vaccine. 2006 Mar 15;24(12):2043-8. Epub 2005 Nov 28.

PMID:
16356597
25.

Nucleic Acid amplification tests for diagnosis of Bordetella infections.

Riffelmann M, Wirsing von König CH, Caro V, Guiso N; Pertussis PCR Consesus Group.

J Clin Microbiol. 2005 Oct;43(10):4925-9. Review. No abstract available.

26.

Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies.

Caro V, Njamkepo E, Van Amersfoorth SC, Mooi FR, Advani A, Hallander HO, He Q, Mertsola J, Riffelmann M, Vahrenholz C, Von König CH, Guiso N.

Microbes Infect. 2005 Jun;7(7-8):976-82.

PMID:
15994109
27.

Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

van Amersfoorth SC, Schouls LM, van der Heide HG, Advani A, Hallander HO, Bondeson K, von König CH, Riffelmann M, Vahrenholz C, Guiso N, Caro V, Njamkepo E, He Q, Mertsola J, Mooi FR.

J Clin Microbiol. 2005 Jun;43(6):2837-43.

28.

The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis.

Bonhoeffer J, Bär G, Riffelmann M, Solèr M, Heininger U.

Infection. 2005 Feb;33(1):13-7.

PMID:
15750754
29.

External quality assessment for molecular detection of Bordetella pertussis in European laboratories.

Muyldermans G, Soetens O, Antoine M, Bruisten S, Vincart B, Doucet-Populaire F, Fry NK, Olcén P, Scheftel JM, Senterre JM, van der Zee A, Riffelmann M, Piérard D, Lauwers S.

J Clin Microbiol. 2005 Jan;43(1):30-5.

30.

[Anthrax. Basic principles and preventive measures].

Maiwald-Schirra C, Riffelmann M, Wirsing von König CH.

Kinderkrankenschwester. 2001 Dec;20(12):511-4. German. No abstract available.

PMID:
14584137
31.

Fatal influenza A virus infection in a child vaccinated against influenza.

Thomas P, Riffelmann M, Schweiger B, Dominik S, von König CH.

Pediatr Infect Dis J. 2003 Feb;22(2):201-2.

PMID:
12613460
32.

Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines.

Schöndorf T, Neumann R, Benz C, Becker M, Riffelmann M, Göhring UJ, Sartorius J, von König CH, Breidenbach M, Valter MM, Hoopmann M, Di Nicolantonio F, Kurbacher CM.

Recent Results Cancer Res. 2003;161:111-6.

PMID:
12528803
33.

Pertussis of adults and infants.

von König CH, Halperin S, Riffelmann M, Guiso N.

Lancet Infect Dis. 2002 Dec;2(12):744-50. Review.

PMID:
12467690
34.

Antibodies to pertussis antigens in pediatric health care workers.

Riffelmann M, Koesters K, Saemann-Ischenko G, Schmitt HJ, Wirsing von Koenig CH.

Pediatr Infect Dis J. 2002 May;21(5):381-3.

PMID:
12150172
35.

Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis.

Kösters K, Reischl U, Schmetz J, Riffelmann M, Wirsing von König CH.

J Clin Microbiol. 2002 May;40(5):1719-22.

36.

Stability of antibodies to Bordetella antigens in German adults.

Saemann-Ischenko G, Tillmanns B, Kösters K, Riffelmann M, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2001 Dec;20(12):850-3.

PMID:
11837635
37.

Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples.

Kösters K, Riffelmann M, Wirsing von König CH.

J Med Microbiol. 2001 May;50(5):436-40.

PMID:
11339251
38.

Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Kösters K, Riffelmann M, Dohrn B, von König CH.

Clin Diagn Lab Immunol. 2000 May;7(3):422-6.

39.

[Travel vaccinations for children].

Wirsing von König CH, Riffelmann M.

Kinderkrankenschwester. 1999 Aug;18(8):322-6. German. No abstract available.

PMID:
10531945
40.

Transmission of GBV-C/HGV from drug-addicted mothers to their babies.

Viazov S, Riffelmann M, Sarr S, Ballauff A, Meisel H, Roggendorf M.

J Hepatol. 1997 Jul;27(1):85-90.

PMID:
9252078
41.

Genetic heterogeneity of hepatitis G virus isolates from different parts of the world.

Viazov S, Riffelmann M, Khoudyakov Y, Fields H, Varenholz C, Roggendorf M.

J Gen Virol. 1997 Mar;78 ( Pt 3):577-81.

PMID:
9049408
42.

Rational use of diagnostic tools in hepatitis C.

Roggendorf M, Lu M, Meisel H, Riffelmann M, Schreier E, Viazov S.

J Hepatol. 1996;24(2 Suppl):26-34. Review.

PMID:
8836886
43.

Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons.

Riffelmann M, Müller G, Schmieding W, Popp W, Norpoth K.

Int Arch Occup Environ Health. 1995;68(1):36-43.

PMID:
8847111
44.

[Perinatal infection by hepatitis C viruses].

Riffelmann M.

Dtsch Med Wochenschr. 1994 Jun 3;119(22):825. German. No abstract available.

PMID:
8205948

Supplemental Content

Loading ...
Support Center